Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.
Open Forum Infect Dis
; 9(8): ofac382, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-2299657
ABSTRACT
Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these patients with difficult-to-treat infections.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Open Forum Infect Dis
Year:
2022
Document Type:
Article
Affiliation country:
Ofid
Similar
MEDLINE
...
LILACS
LIS